Hepatitis C virus inhibitors

Details for Australian Patent Application No. 2007286222 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Martel, Alain; Yang, Fukang; Langley, David R.; Goodrich, Jason; Romine, Jeffrey Lee; Belema, Makonen; St. Laurent, Denis R.; James, Clint A.; Bachand, Carol; Nguyen, Van N.; Wang, Gan; Deon, Daniel H.; Lavoie, Rico; Meanwell, Nicholas A.; Good, Andrew C.; Hamann, Lawrence G.; Lopez, Omar D.; Ruediger, Edward H.; Snyder, Lawrence B.

Agent A J Park

Pub. Number AU-B-2007286222

PCT Pub. Number WO2008/021927

Priority 11/835,462 08.08.07 US; 60/836,996 11.08.06 US

Filing date 9 August 2007

Wipo publication date 21 February 2008

Acceptance publication date 28 June 2012

International Classifications

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

A61K 31/4025 - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/4178

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 403/14 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/021927 Priority application(s): WO2008/021927

28 June 2012 Application Accepted

  Published as AU-B-2007286222

25 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007286223-Hepatitis C virus inhibitors

2007286221-Modulators of glucocorticoid receptor, and/or AP-1, and/or NF-KB activity and use thereof